BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang YC, Chien MH, Lai TC, Tung MC, Jan YH, Chang WM, Jung SM, Chen MH, Yeh CN, Hsiao M. Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma. J Biomed Sci 2021;28:29. [PMID: 33888099 DOI: 10.1186/s12929-021-00727-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Gao W, Zhang ZW, Wang HY, Li XD, Peng WT, Guan HY, Liao YX, Liu A. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma. Front Genet 2022;13:895281. [PMID: 35754792 DOI: 10.3389/fgene.2022.895281] [Reference Citation Analysis]
2 Luo Y, Da D, Weng Q, Yao S, Zhang H, Han X, Zhang Y. miR-296–5p promotes autophagy in mouse LS8 cells under excessive fluoride via AMPK/ULK1 pathways. Ecotoxicology and Environmental Safety 2022;235:113362. [DOI: 10.1016/j.ecoenv.2022.113362] [Reference Citation Analysis]
3 Ju G, Xu C, Zeng K, Zhou T, Zang L. High expression of transmembrane P24 trafficking protein 9 predicts poor prognosis in breast carcinoma. Bioengineered 2021;12:8965-79. [PMID: 34635011 DOI: 10.1080/21655979.2021.1990673] [Reference Citation Analysis]
4 Ullah MA, Tabassum T, Farzana M, Moin AT, Zohora US, Rahman MS. Expression analysis, molecular characterization and prognostic evaluation on TMED4 and TMED9 gene expression in glioma. Biomedical Signal Processing and Control 2022;78:103922. [DOI: 10.1016/j.bspc.2022.103922] [Reference Citation Analysis]